Correlation Between Kiora Pharmaceuticals and Vericel Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Vericel Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Vericel Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Vericel Corp Ord, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Vericel Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Vericel Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Vericel Corp.

Diversification Opportunities for Kiora Pharmaceuticals and Vericel Corp

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Kiora and Vericel is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Vericel Corp Ord in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vericel Corp Ord and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Vericel Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vericel Corp Ord has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Vericel Corp go up and down completely randomly.

Pair Corralation between Kiora Pharmaceuticals and Vericel Corp

Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 5.6 times less return on investment than Vericel Corp. In addition to that, Kiora Pharmaceuticals is 2.25 times more volatile than Vericel Corp Ord. It trades about 0.01 of its total potential returns per unit of risk. Vericel Corp Ord is currently generating about 0.09 per unit of volatility. If you would invest  3,554  in Vericel Corp Ord on August 26, 2024 and sell it today you would earn a total of  2,357  from holding Vericel Corp Ord or generate 66.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kiora Pharmaceuticals  vs.  Vericel Corp Ord

 Performance 
       Timeline  
Kiora Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Kiora Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Vericel Corp Ord 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Vericel Corp disclosed solid returns over the last few months and may actually be approaching a breakup point.

Kiora Pharmaceuticals and Vericel Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kiora Pharmaceuticals and Vericel Corp

The main advantage of trading using opposite Kiora Pharmaceuticals and Vericel Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Vericel Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vericel Corp will offset losses from the drop in Vericel Corp's long position.
The idea behind Kiora Pharmaceuticals and Vericel Corp Ord pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities